Houston Shock Symposium
E

Why Is Epinephrine Not the Drug of Choice for Cardiogenic Shock

By Houston Shock Symposium FEATURING Esther Vorovich
By Houston Shock Symposium FEATURING Esther Vorovich
2,117 views
March 10, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

11:07
Abiomed

Jacob Møller, MD: DanGer Shock RCT Results

Feat. J. Møller

Related Content

AUTOPLAY
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
11:22
John McPherson

Therapeutic Hypothermia After Cardiac Arrest

17:25
Houston Shock Symposium

IABP in Shock: Do Kinetics Differ Based on Cannulation Strategy?

Feat. A. Civitello
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
29:08
Scripps Health

Case Presentation: Complex PCI with IABP

Feat. R. Khedraki, T. Heywood, R. Mohan, A. Srivastava
30:04
Scripps Health

Menopause, Hormone Therapy, and the Heart: What the Evidence Shows

Feat. C. Shufelt
09:50
The Cardiogenic Shock Working Group

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

Feat. N. Kapur
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
17:36
Mount Sinai Advanced Innovations in Heart Failure

Contemporary Management of Cardiogenic Shock: Updates in 2022

Feat. D. Baran
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
34:18
Scripps Health

Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…

Feat. A. Kuo
84:17
Jefferson Health

2022 Heart Failure Guidelines Review

Feat. D. Haas
20:59
Mary E. Money

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

14:21
Heart of Battle: Sentara Shock Symposium

Cardiogenic Shock Case Presentation